Fifth Third Bancorp’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Buy |
23,848
+16,332
| +217% | +$10.5M | 0.02% | 387 |
|
|
2025
Q4 | $5.08M | Buy |
7,516
+142
| +2% | +$96.7K | 0.02% | 313 |
|
|
2025
Q3 | $4.71M | Buy |
7,374
+1,392
| +23% | +$845K | 0.02% | 322 |
|
|
2025
Q2 | $3.21M | Sell |
5,982
-93
| -2% | -$44.5K | 0.01% | 371 |
|
|
2025
Q1 | $2.55M | Buy |
6,075
+3,071
| +102% | +$1.33M | 0.01% | 409 |
|
|
2024
Q4 | $1.24M | Sell |
3,004
-3,708
| -55% | -$1.63M | ﹤0.01% | 542 |
|
|
2024
Q3 | $3.39M | Sell |
6,712
-772
| -10% | -$375K | 0.01% | 384 |
|
|
2024
Q2 | $3.65M | Sell |
7,484
-234
| -3% | -$117K | 0.01% | 349 |
|
|
2024
Q1 | $4.17M | Buy |
7,718
+1
| +0% | +$546 | 0.02% | 339 |
|
|
2023
Q4 | $4.28M | Sell |
7,717
-143
| -2% | -$67.1K | 0.02% | 322 |
|
|
2023
Q3 | $3.44M | Sell |
7,860
-5,398
| -41% | -$2.69M | 0.02% | 351 |
|
|
2023
Q2 | $6.66M | Sell |
13,258
-277
| -2% | -$133K | 0.03% | 283 |
|
|
2023
Q1 | $6.77M | Buy |
13,535
+2,076
| +18% | +$993K | 0.03% | 281 |
|
|
2022
Q4 | $4.67M | Buy |
11,459
+4,225
| +58% | +$1.64M | 0.02% | 321 |
|
|
2022
Q3 | $2.36M | Buy |
7,234
+257
| +4% | +$94.4K | 0.01% | 403 |
|
|
2022
Q2 | $2.45M | Sell |
6,977
-5,525
| -44% | -$2.25M | 0.01% | 404 |
|
|
2022
Q1 | $6.84M | Buy |
12,502
+260
| +2% | +$137K | 0.03% | 305 |
|
|
2021
Q4 | $8.06M | Buy |
12,242
+435
| +4% | +$273K | 0.03% | 298 |
|
|
2021
Q3 | $7.34M | Buy |
11,807
+388
| +3% | +$261K | 0.03% | 299 |
|
|
2021
Q2 | $7.21M | Buy |
11,419
+489
| +4% | +$270K | 0.03% | 298 |
|
|
2021
Q1 | $5.35M | Buy |
10,930
+729
| +7% | +$365K | 0.02% | 338 |
|
|
2020
Q4 | $5.1M | Buy |
10,201
+1,501
| +17% | +$672K | 0.03% | 328 |
|
|
2020
Q3 | $3.42M | Buy |
8,700
+6,089
| +233% | +$2.25M | 0.02% | 364 |
|
|
2020
Q2 | $862K | Buy |
2,611
+595
| +30% | +$172K | 0.01% | 533 |
|
|
2020
Q1 | $488K | Buy |
2,016
+599
| +42% | +$156K | ﹤0.01% | 601 |
|
|
2019
Q4 | $370K | Buy |
1,417
+346
| +32% | +$91.2K | ﹤0.01% | 737 |
|
|
2019
Q3 | $291K | Buy |
1,071
+215
| +25% | +$59.8K | ﹤0.01% | 804 |
|
|
2019
Q2 | $236K | Buy |
856
+347
| +68% | +$85.5K | ﹤0.01% | 865 |
|
|
2019
Q1 | $114K | Buy |
509
+149
| +41% | +$30.8K | ﹤0.01% | 1022 |
|
|
2018
Q4 | $67K | Sell |
360
-28
| -7% | -$5.74K | ﹤0.01% | 1149 |
|
|
2018
Q3 | $97K | Buy |
388
+170
| +78% | +$41.3K | ﹤0.01% | 1103 |
|
|
2018
Q2 | $48K | Buy |
218
+102
| +88% | +$21K | ﹤0.01% | 1327 |
|
|
2018
Q1 | $22K | Buy |
116
+50
| +76% | +$9.23K | ﹤0.01% | 1628 |
|
|
2017
Q4 | $10K | Buy |
66
+45
| +214% | +$7.08K | ﹤0.01% | 1825 |
|
|
2017
Q3 | $3K | Buy |
21
+7
| +50% | +$1.11K | ﹤0.01% | 1996 |
|
|
2017
Q2 | $2K | Buy |
+14
| New | +$2.27K | ﹤0.01% | 2048 |
|
|
2016
Q2 | – | Sell |
-70
| Closed | -$5K | – | 2283 |
|
|
2016
Q1 | $5K | Sell |
70
-254
| -78% | -$18.3K | ﹤0.01% | 2018 |
|
|
2015
Q4 | $24K | Buy |
324
+2
| +0.6% | +$143 | ﹤0.01% | 1618 |
|
|
2015
Q3 | $24K | Buy |
322
+19
| +6% | +$1.36K | ﹤0.01% | 1660 |
|
|
2015
Q2 | $19K | Sell |
303
-149
| -33% | -$10.3K | ﹤0.01% | 1827 |
|
|
2015
Q1 | $35K | Buy |
+452
| New | +$35.2K | ﹤0.01% | 1544 |
|
|
2013
Q3 | – | Sell |
-346
| Closed | -$16K | – | 2231 |
|
|
2013
Q2 | $16K | Buy |
+346
| New | +$15.1K | ﹤0.01% | 1657 |
|
Other funds holding IDXX
VCM
VPM
Fifth Third Bancorp's IDXX Position: Q1 2026 in Review
Fifth Third Bancorp increased its Idexx Laboratories (IDXX) stake by 217% in Q1 2026, buying an estimated $10.5M and bringing the position to 23,848 shares worth $13.4M. The position accounts for 0.02% of the portfolio, ranked #387.
Fifth Third Bancorp first reported a position in IDXX in Q2 2013 and has held it in 42 quarters since. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Fifth Third Bancorp held 23,848 shares of Idexx Laboratories worth $13.4M as of Q1 2026.
- Fifth Third Bancorp bought 16,332 Idexx Laboratories shares in Q1 2026, an estimated $10.5M.
- Idexx Laboratories made up 0.02% of Fifth Third Bancorp's portfolio in Q1 2026, its #387 holding.
- Fifth Third Bancorp first reported a position in Idexx Laboratories in Q2 2013 and has held it in 42 quarters since.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.